Home > Boards > US Listed > Biotechs > Sarepta Therapeutics (SRPT)

Huge announcement of new CEO + earnings coming

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
fredugsi Member Profile
 
Followed By 8
Posts 739
Boards Moderated 0
Alias Born 10/06/08
160x600 placeholder
Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeu... GlobeNewswire Inc. - 1/13/2021 8:30:00 AM
Sarepta Stock Gets Mixed Reviews From Analysts TipRanks - 1/11/2021 8:01:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 10:33:38 AM
Eli Lilly, Twitter, NIO: What to Watch When the Stock Market Opens Today Dow Jones News - 1/11/2021 8:12:00 AM
Eli Lilly, Twitter, NIO: What to Watch When the Stock Market Opens Today Dow Jones News - 1/11/2021 7:32:00 AM
Is Sarepta Stock Worth Buying After the 50% Plunge? Analyst Weighs In TipRanks - 1/8/2021 11:44:53 AM
Tesla, Sarepta, Boeing: What to Watch When the Stock Market Opens Today Dow Jones News - 1/8/2021 9:25:00 AM
Tesla, Sarepta, Boeing: What to Watch When the Stock Market Opens Today Dow Jones News - 1/8/2021 9:08:00 AM
Sarepta Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/8/2021 8:30:00 AM
Tesla, Sarepta, Boeing: What to Watch When the Stock Market Opens Today Dow Jones News - 1/8/2021 8:27:00 AM
Tesla, Sarepta, Boeing: What to Watch When the Stock Market Opens Today Dow Jones News - 1/8/2021 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2021 5:04:31 PM
Sarepta Therapeutics Announces Top-line Results for Part 1 of Study 102 Evaluating SRP-9001, its Investigational Gene Therapy... GlobeNewswire Inc. - 1/7/2021 4:05:00 PM
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 12/31/2020 6:30:00 PM
Sarepta Therapeutics Announces Executive Management Changes GlobeNewswire Inc. - 12/14/2020 8:30:00 AM
Sarepta Therapeutics Announces Positive Clinical Results from MOMENTUM, a Phase 2 Clinical Trial of SRP-5051 in Patients with... GlobeNewswire Inc. - 12/7/2020 8:55:00 AM
Sarepta Therapeutics to Share Clinical Update for SRP-5051, its Investigational PPMO for the Treatment of Duchenne Muscular D... GlobeNewswire Inc. - 12/4/2020 4:05:00 PM
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 11/30/2020 6:05:00 PM
Sarepta Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference GlobeNewswire Inc. - 11/25/2020 8:30:00 AM
Sarepta Therapeutics Named One of The Boston Globe’s Top Places to Work 2020 GlobeNewswire Inc. - 11/20/2020 8:30:00 AM
Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments GlobeNewswire Inc. - 11/5/2020 4:05:00 PM
Sarepta Therapeutics to Commence Dosing of the Next Study with Commercial Process Material for the SRP-9001 Gene Therapy Prog... GlobeNewswire Inc. - 11/5/2020 4:02:00 PM
Sarepta Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference GlobeNewswire Inc. - 11/2/2020 4:30:00 PM
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 10/30/2020 7:15:57 PM
Sarepta Therapeutics to Announce Third Quarter 2020 Financial Results and Recent Corporate Developments on November 5, 2020 GlobeNewswire Inc. - 10/29/2020 8:35:56 AM
fredugsi   Wednesday, 06/28/17 06:09:17 PM
Re: None
Post # of 2897 
Huge announcement of new CEO + earnings coming 7/19. Rumors of their new drug also helps in reducing migraines? A screaming buy!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences